NeoGenomics, Inc.
NeoGenomics, Inc. is a clinical laboratory focused on cancer genetics tests and related services.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding NeoGenomics' stock with a target price of $10.05, indicating limited growth.
Financial Health
NeoGenomics is generating steady revenue and cash flow, but its profitability is low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring NEO
The Alzheimer's Treatment Ecosystem
Following the EU regulator's approval of Eli Lilly's Alzheimer's drug, Kisunla, a new investment opportunity has emerged. This theme focuses on companies that provide essential support services, such as genetic testing and advanced imaging, which are crucial for the drug's administration and monitoring.
Published: July 27, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketLiquid-Biopsy Diagnostics
These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Tumour Profiling Growth
Rising demand for personalised oncology tests supports revenue expansion, though adoption rates and pricing can vary by region and payer.
Lab Network Expansion
Acquisitions and capacity investments can drive scale and service breadth, but integration and execution risks may affect near‑term margins.
Reimbursement Sensitivity
Revenue is sensitive to reimbursement policies and insurer decisions; favourable coverage boosts volumes, while cuts can pressure earnings.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
UnitedHealth Group Incorporated
Provides healthcare services to individuals and organizations
CVS Health Corporation
CVS Health is a healthcare company that provides pharmacy, health insurance, and other healthcare services.
HCA Holdings, Inc.
A healthcare services company dedicated to providing high quality, cost effective care.
